Authors: Karin Meijer1,2, Irma van Dijk1,2, Marije Frank1, Arnout van den Hoek1, Brian Balgobind1,2, Geert Janssens3,4, Markus Wendling5, John Maduro6,3, Abigail Bryce-Atkinson7, Anna Loginova8, Arjan Bel1,2
1Amsterdam UMC, University of Amsterdam, Radiation Oncology, Amsterdam, The Netherlands; 2Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands; 3Princess Máxima Center, Pediatric Oncology, Utrecht, The Netherlands; 4University Medical Center Utrecht, Radiation Oncology, Utrecht, The Netherlands; 5Radboud University Medical Center, Radiation Oncology, Nijmegen, The Netherlands; 6University Medical Center Groningen, University of Groningen, Radiation Oncology, Groningen, The Netherlands; 7School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom; 8Federal Research and Clinical Center of Pediatric Hematology, Oncology and Immunology, Radiation Oncology, Moscow, Russian Federation